M. Picó

Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options

In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy

Recombinant factor VIIa in continuous infusion during central line insertion in a child with factor VIII high‐titre inhibitor

[Platelet function study in primary Raynaud's phenomenon and Raynaud's phenomenon associated with scleroderma].